Acute Myocardial Rescue with Endogenous Endothelial Progenitor Cell Therapy

被引:16
作者
Atluri, Pavan [1 ]
Panlilio, Corinna M. [1 ]
Liao, George P. [1 ]
Hiesinger, William [1 ]
Harris, David Andrew [1 ]
McCormick, Ryan C. [1 ]
Cohen, Jeffrey E. [1 ]
Jin, Tao [1 ]
Feng, Wei [1 ]
Levit, Rebecca D. [1 ]
Dong, Nianguo [1 ]
Woo, Y. Joseph [1 ]
机构
[1] Univ Penn, Sch Med, Dept Surg, Div Cardiovasc Surg, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
Vasculogenesis; Granulocyte-macrophage colony stimulating factor; Stromal cell derived factor; Endothelial progenitor cell; Ischaemia; CORONARY-ARTERY-DISEASE; REDUCED NEOVASCULARIZATION CAPACITY; CONGESTIVE-HEART-FAILURE; BONE-MARROW; ISCHEMIC CARDIOMYOPATHY; CARDIAC-FUNCTION; NEOVASCULOGENIC THERAPY; ANGIOGENIC CYTOKINES; MONONUCLEAR-CELLS; GROWTH-HORMONE;
D O I
10.1016/j.hlc.2010.06.1056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Post-myocardial infarction heart failure is a major health concern with limited therapy. Molecular revascularisation utilising granulocyte-macrophage colony stimulating factor (GMCSF) mediated endothelial progenitor cell (EPC) upregulation and stromal cell derived factor-1 alpha (SDF) mediated myocardial EPC chemokinesis, may prevent myocardial loss and adverse remodelling. Vasculogenesis, viability, and haemodynamic improvements following therapy were investigated. Procedures: Lewis rats (n = 91) underwent LAD ligation and received either intramyocardial SDF and subcutaneous GMCSF or saline injections at the time of infarction. Molecular and haemodynamic assessments were performed at pre-determined time points following ligation. Findings: SDF/GMCSF therapy upregulated EPC density as shown by flow cytometry (0.12 +/- 0.02% vs. 0.06 +/- 0.01% circulating lymphocytes, p = 0.005), 48 hours following infarction. A marked increase in perfusion was evident eight weeks after therapy, utilising confocal angiography (5.02 +/- 1.7 x 10(-2) mu m(3) blood/mu m(3) myocardial tissue vs. 2.03 +/- 0.710(-2) mu m(3) blood/mu m(3) myocardial tissue, p = 0.00004). Planimetric analysis demonstrated preservation of wall thickness (0.98 +/- 0.09 mm vs. 0.67 +/- 0.06 mm,p = 0.003) and ventricular diameter (7.81 +/- 0.99 mm vs. 9.41 +/- 1.1 mm,p = 0.03). Improved haemodynamic function was evidenced by echocardiography and PV analysis (ejection fraction: 56.4 +/- 18.1% vs. 25.3 +/- 1 15.6%, p = 0.001; pre-load adjusted maximal power: 6.6 +/- 2.6 mW/mu l(2) vs. 2.7 +/- 1.4 mW/mu l(2), p = 0.01). Conclusion: Neovasculogenic therapy with GMCSF-mediated EPC upregulation and SDF-mediated EPC chemokinesis maybe an effective therapy for infarct modulation and preservation of myocardial function following acute myocardial infarction. (Heart, Lung and Circulation 2010;19:644-654) (C) 2010 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and New Zealand. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:644 / 654
页数:11
相关论文
共 47 条
[1]   Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury [J].
Abbott, JD ;
Huang, Y ;
Liu, D ;
Hickey, R ;
Krause, DS ;
Giordano, FJ .
CIRCULATION, 2004, 110 (21) :3300-3305
[2]   Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction -: (TOPCARE-AMI) [J].
Assmus, B ;
Schächinger, V ;
Teupe, C ;
Britten, M ;
Lehmann, R ;
Döbert, N ;
Grünwald, F ;
Aicher, A ;
Urbich, C ;
Martin, H ;
Hoelzer, D ;
Dimmeler, S ;
Zeiher, AM .
CIRCULATION, 2002, 106 (24) :3009-3017
[3]   Transcoronary transplantation of progenitor cells after myocardial infarction [J].
Assmus, Birgit ;
Honold, Joerg ;
Schaechinger, Volker ;
Britten, Martina B. ;
Fischer-Rasokat, Ulrich ;
Lehmann, Ralf ;
Teupe, Claudius ;
Pistorius, Katrin ;
Martin, Hans ;
Abolmaali, Nasreddin D. ;
Tonn, Torsten ;
Dimmeler, Stefanie ;
Zeiher, Andreas M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12) :1222-1232
[4]   Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy - Invited commentary [J].
Atluri, P ;
Liao, GP ;
Panlilio, CM ;
Hsu, VM ;
Leskowitz, MJ ;
Morine, KJ ;
Cohen, JE ;
Berry, MF ;
Suarez, EE ;
Murphy, DA ;
Lee, WMF ;
Gardner, TJ ;
Sweeney, HL ;
Woo, YJ ;
Dormond, O ;
Madsen, JC .
ANNALS OF THORACIC SURGERY, 2006, 81 (05) :1728-1737
[5]   Pro-angiogenic cytokines as cardiovascular therapeutics - Assessing the potential [J].
Atluri, Pavan ;
Woo, Y. Joseph .
BIODRUGS, 2008, 22 (04) :209-222
[6]   Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248 [J].
Bagley, Rebecca G. ;
Rouleau, Cecile ;
St. Martin, Thia ;
Boutin, Paula ;
Weber, William ;
Ruzek, Melanie ;
Honma, Nakayuki ;
Nacht, Mariana ;
Shankara, Srinivas ;
Kataoka, Shiro ;
Ishida, Isao ;
Roberts, Bruce L. ;
Teicher, Beverly A. .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (08) :2536-2546
[7]   Learning from failure: congestive heart failure in the postgenomic age [J].
Benjamin, IJ ;
Schneider, MD .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (03) :495-499
[8]   RETRACTED: The future of therapeutic myocardial angiogenesis (Retracted Article) [J].
Boodhwani, Munir ;
Sodha, Neel R. ;
Laham, Roger J. ;
Sellke, Frank W. .
SHOCK, 2006, 26 (04) :332-341
[9]  
Braunwald E, 2000, CIRCULATION, V102, P14
[10]   Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI) -: Mechanistic insights from serial contrast-enhanced magnetic resonance imaging [J].
Britten, MB ;
Abolmaali, ND ;
Assmus, B ;
Lehmann, R ;
Honold, J ;
Schmitt, J ;
Vogl, TJ ;
Martin, H ;
Schächinger, V ;
Dimmeler, S ;
Zeiher, AM .
CIRCULATION, 2003, 108 (18) :2212-2218